CAVALETTI, GUIDO ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 48.301
EU - Europa 22.963
AS - Asia 11.311
SA - Sud America 121
OC - Oceania 108
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 59
Totale 82.923
Nazione #
US - Stati Uniti d'America 47.411
IT - Italia 4.400
CN - Cina 4.225
SG - Singapore 3.776
DE - Germania 3.707
SE - Svezia 3.245
IE - Irlanda 3.160
RU - Federazione Russa 2.511
UA - Ucraina 2.408
HK - Hong Kong 1.287
GB - Regno Unito 1.101
CA - Canada 859
FI - Finlandia 650
VN - Vietnam 488
AT - Austria 452
FR - Francia 388
ID - Indonesia 364
IN - India 338
DK - Danimarca 263
TR - Turchia 195
JP - Giappone 188
NL - Olanda 186
KR - Corea 180
BE - Belgio 133
AU - Australia 87
BR - Brasile 79
PL - Polonia 64
IR - Iran 60
ES - Italia 55
EU - Europa 53
TW - Taiwan 46
MY - Malesia 36
CZ - Repubblica Ceca 35
PT - Portogallo 32
CH - Svizzera 30
RO - Romania 28
PK - Pakistan 24
EG - Egitto 22
NZ - Nuova Zelanda 21
GR - Grecia 20
HR - Croazia 19
MX - Messico 17
PH - Filippine 16
BG - Bulgaria 12
IL - Israele 12
NO - Norvegia 12
PE - Perù 12
UZ - Uzbekistan 12
RS - Serbia 11
CL - Cile 10
SC - Seychelles 10
TH - Thailandia 10
ZA - Sudafrica 10
IQ - Iraq 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
AR - Argentina 7
GT - Guatemala 6
HU - Ungheria 6
LT - Lituania 6
LU - Lussemburgo 6
MD - Moldavia 6
BD - Bangladesh 5
CO - Colombia 5
LB - Libano 5
SI - Slovenia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
MU - Mauritius 4
TN - Tunisia 4
A1 - Anonimo 3
AL - Albania 3
KW - Kuwait 3
BH - Bahrain 2
BY - Bielorussia 2
ET - Etiopia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MN - Mongolia 2
MT - Malta 2
NG - Nigeria 2
PA - Panama 2
TT - Trinidad e Tobago 2
UG - Uganda 2
YE - Yemen 2
AZ - Azerbaigian 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MA - Marocco 1
MM - Myanmar 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TZ - Tanzania 1
Totale 82.923
Città #
Ann Arbor 9.449
Woodbridge 4.641
Fairfield 3.560
Houston 3.432
Singapore 3.139
Dublin 3.069
Chandler 2.845
Jacksonville 2.527
Frankfurt am Main 2.288
Wilmington 2.277
Ashburn 2.168
Dearborn 1.763
Milan 1.376
Seattle 1.375
Princeton 1.244
Hong Kong 1.240
New York 1.235
Santa Clara 1.185
Cambridge 1.183
Nanjing 719
Boardman 578
Shanghai 503
Lawrence 459
Altamura 450
Hangzhou 450
Vienna 431
Beijing 419
Lachine 413
Jakarta 355
Dong Ket 256
Guangzhou 251
Nanchang 219
Andover 204
San Diego 202
Helsinki 200
Toronto 200
Shenyang 195
Hebei 154
Rome 150
Falls Church 134
Tianjin 123
Ottawa 119
Chicago 117
Changsha 116
Fremont 116
Jiaxing 116
Grafing 112
Kazan 112
Jinan 110
Brussels 107
Mountain View 100
Los Angeles 90
London 89
Norwalk 88
Huizen 85
Pune 85
Detroit 78
Kunming 75
Ningbo 71
Zhengzhou 67
Carate Brianza 59
Nürnberg 58
Melzo 57
Hefei 55
Dallas 53
Edmonton 50
Florence 47
San Mateo 47
Washington 46
Munich 44
Redmond 43
Tokyo 43
Leawood 38
Daejeon 37
Lissone 34
Turin 33
Phoenix 32
Sydney 32
Taizhou 32
Sacramento 31
Bologna 30
Kiev 29
Paris 29
Auburn Hills 28
Bergamo 28
Bari 27
Naples 27
Philadelphia 27
Saint Petersburg 27
University Park 27
Brno 26
Romola 26
Lappeenranta 25
Catania 24
Kocaeli 24
Mainz 24
Fuzhou 23
Shangdi 22
Chengdu 21
Desio 21
Totale 60.300
Nome #
La citofluorimetria a flusso nella caratterizzazione immunofenotipica dei linfociti in corso di Encefalite Autoimmune Sperimentale. 492
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 416
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 383
Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment 351
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 347
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 333
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 323
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 308
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 305
Malattie del Sistema Nervoso 303
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 300
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 297
Age-related changes in the function and structure of the peripheral sensory pathway in mice 297
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 292
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 292
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 292
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 290
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 286
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 284
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 284
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 273
The Italian multiple sclerosis register 270
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 266
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 265
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 259
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 256
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 253
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 250
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 249
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 248
Enhanced brain targeting of engineered solid lipid nanoparticles 239
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 239
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 239
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 236
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 233
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 233
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 233
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 233
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 232
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 230
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 220
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 219
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 219
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 219
Malattie del Sistema Nervoso 219
Are sigma receptor modulators a weapon against multiple sclerosis disease? 218
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 218
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 216
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y 213
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 211
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 209
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 208
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 208
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 208
Role of MAPKs in platinum-induced neuronal apoptosis 206
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 206
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 201
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 200
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 200
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 199
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 198
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 198
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline 198
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 197
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 197
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 195
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis 193
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 192
An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy 189
Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells 188
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 188
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 188
NCI Clinical Trials Planning Meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy 188
Histological features of nerve fibers and endoneural vessels in a case of Wegener's granulomatosis. 186
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 186
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 186
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 185
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 185
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 185
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 185
Pain in chemotherapy-induced peripheral neurotoxicity 185
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 185
Hemorrhagic infarction: risk factors, clinical and tomographic features, and outcome. A case-control study 184
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 183
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 182
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 181
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases 181
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 180
The Italian neuromuscular registry: A coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage 180
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 180
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools 180
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 179
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 178
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 178
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 177
A clinico-pathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy 176
Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology 176
Enhanced brain targeting of engineered solid lipid nanoparticles 176
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 176
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 175
Totale 23.027
Categoria #
all - tutte 304.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 304.809


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.199 0 0 0 0 0 1.723 2.088 994 1.315 900 898 281
2020/202111.730 705 487 1.422 1.222 840 908 1.351 1.075 1.006 1.072 606 1.036
2021/20227.268 464 759 732 672 492 676 355 400 350 499 561 1.308
2022/202312.644 1.552 3.530 1.184 1.077 893 1.970 170 657 896 141 314 260
2023/202410.575 335 389 450 424 1.434 2.369 1.959 439 786 247 246 1.497
2024/202510.386 1.585 2.872 1.748 1.200 2.163 818 0 0 0 0 0 0
Totale 86.893